Repligen [RGEN] vs Becton, Dickinson [BDX] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Repligen wins in 3 metrics, Becton, Dickinson wins in 16 metrics, with 0 ties. Becton, Dickinson appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricRepligenBecton, DickinsonBetter
P/E Ratio (TTM)511.1135.46Becton, Dickinson
Price-to-Book Ratio4.062.18Becton, Dickinson
Debt-to-Equity Ratio33.2875.93Repligen
PEG Ratio3.191.86Becton, Dickinson
EV/EBITDA65.9912.52Becton, Dickinson
Profit Margin (TTM)-2.05%7.41%Becton, Dickinson
Operating Margin (TTM)5.28%17.81%Becton, Dickinson
EBITDA Margin (TTM)5.28%17.81%Becton, Dickinson
Return on Equity-0.68%6.18%Becton, Dickinson
Return on Assets (TTM)1.13%3.96%Becton, Dickinson
Free Cash Flow (TTM)$142.49M$3.07BBecton, Dickinson
Dividend YieldN/A1.80%N/A
1-Year Return8.13%-18.82%Repligen
Price-to-Sales Ratio (TTM)12.422.59Becton, Dickinson
Enterprise Value$8.34B$74.08BBecton, Dickinson
EV/Revenue Ratio12.383.46Becton, Dickinson
Gross Profit Margin (TTM)49.98%47.81%Repligen
Revenue per Share (TTM)$12$74Becton, Dickinson
Earnings per Share (Diluted)$-0.25$5.46Becton, Dickinson
Beta (Stock Volatility)1.090.28Becton, Dickinson
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Repligen vs Becton, Dickinson Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Repligen0.92%20.96%24.36%20.63%29.27%4.93%
Becton, Dickinson-0.84%4.34%0.21%11.01%-6.38%-15.23%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Repligen8.13%-22.44%-12.10%395.87%4,314.71%4,590.63%
Becton, Dickinson-18.82%-14.56%-16.96%41.00%158.50%282.68%

News Based Sentiment: Repligen vs Becton, Dickinson

Repligen

News based Sentiment: POSITIVE

October saw a significant surge in positive analyst coverage for Repligen, with multiple upgrades and price target increases following strong Q2 2025 financial results. This widespread optimism, coupled with a promising outlook for future growth and a strategic partnership, indicates a substantial shift in investor sentiment and positions the company for continued success.

View Repligen News Sentiment Analysis

Becton, Dickinson

News based Sentiment: POSITIVE

BDX delivered a strong October, exceeding earnings expectations and raising guidance, fueled by strategic investments in pharmacy automation and continued institutional support. While insider selling is a minor concern, the overall narrative points to positive momentum and growth potential, making it a significant month for investors.

View Becton, Dickinson News Sentiment Analysis

Performance & Financial Health Analysis: Repligen vs Becton, Dickinson

MetricRGENBDX
Market Information
Market Cap i$8.37B$55.67B
Market Cap CategoryMid capLarge cap
10 Day Avg. Volume i969,3101,421,540
90 Day Avg. Volume i852,0131,589,433
Last Close$150.10$191.99
52 Week Range$102.97 - $182.52$163.33 - $251.99
% from 52W High-17.76%-23.81%
All-Time High$327.32 (Sep 20, 2021)$287.32 (Jul 24, 2023)
% from All-Time High-54.14%-33.18%
Growth Metrics
Quarterly Revenue Growth0.15%0.10%
Quarterly Earnings Growth1.60%0.18%
Financial Health
Profit Margin (TTM) i-0.02%0.07%
Operating Margin (TTM) i0.05%0.18%
Return on Equity (TTM) i-0.01%0.06%
Debt to Equity (MRQ) i33.2875.93
Cash & Liquidity
Book Value per Share (MRQ)$36.65$88.87
Cash per Share (MRQ)$12.60$2.64
Operating Cash Flow (TTM) i$132.11M$3.25B
Levered Free Cash Flow (TTM) i$155.35M$3.37B
Dividends
Last 12-Month Dividend Yield iN/A1.80%
Last 12-Month Dividend iN/A$3.03

Valuation & Enterprise Metrics Analysis: Repligen vs Becton, Dickinson

MetricRGENBDX
Price Ratios
P/E Ratio (TTM) i511.1135.46
Forward P/E i83.5612.31
PEG Ratio i3.191.86
Price to Sales (TTM) i12.422.59
Price to Book (MRQ) i4.062.18
Market Capitalization
Market Capitalization i$8.37B$55.67B
Enterprise Value i$8.34B$74.08B
Enterprise Value Metrics
Enterprise to Revenue i12.383.46
Enterprise to EBITDA i65.9912.52
Risk & Other Metrics
Beta i1.090.28
Book Value per Share (MRQ) i$36.65$88.87

Financial Statements Comparison: Repligen vs Becton, Dickinson

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)RGENBDX
Revenue/Sales i$182.37M$5.51B
Cost of Goods Sold i$91.22M$2.88B
Gross Profit i$91.14M$2.63B
Research & Development i$13.96M$297.00M
Operating Income (EBIT) i$5.96M$979.00M
EBITDA i$33.81M$1.57B
Pre-Tax Income i$18.22M$703.00M
Income Tax i$3.35M$129.00M
Net Income (Profit) i$14.87M$574.00M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)RGENBDX
Cash & Equivalents i$697.23M$667.00M
Total Current Assets i$1.03B$8.67B
Total Current Liabilities i$152.00M$7.69B
Long-Term Debt i$668.54M$17.67B
Total Shareholders Equity i$1.99B$25.24B
Retained Earnings i$413.18M$16.15B
Property, Plant & Equipment i$265.24MN/A

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)RGENBDX
Operating Cash Flow i$14.16M$941.00M
Capital Expenditures i$-3.52MN/A
Free Cash Flow i$10.58M$35.00M
Debt Repayment iN/A$-1.00M
Common Stock Repurchase iN/A$0

Short Interest & Institutional Ownership Analysis

MetricRGENBDX
Shares Short i3.54M4.28M
Short Ratio i5.072.41
Short % of Float i0.08%0.02%
Average Daily Volume (10 Day) i969,3101,421,540
Average Daily Volume (90 Day) i852,0131,589,433
Shares Outstanding i56.09M289.10M
Float Shares i52.66M286.00M
% Held by Insiders i0.06%0.01%
% Held by Institutions i0.99%0.92%

Dividend Analysis & Yield Comparison: Repligen vs Becton, Dickinson

MetricRGENBDX
Last 12-Month Dividend iN/A$3.03
Last 12-Month Dividend Yield iN/A1.80%
3-Year Avg Annual Dividend iN/A$3.16
3-Year Avg Dividend Yield iN/A0.40%
3-Year Total Dividends iN/A$9.48
Ex-Dividend DateN/AMar 10, 2025